AUS
NZ
UK
CA
USA
IND
Healthcare
S&P 200 Updates CSL Shares Record One-Day Drop Amid Biotech Restructure
August 19, 2025 02:25 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) experiences significant decline following corporate restructure and strategic announcements.,BHP (ASX:BHP) signals challenges in the Australian economic landscape impacting outlook.,Reliance Worldwide (ASX:RWC), HMC Capital (...
ASX 200 Today CSL Shares Face Volatility Amid Mixed Biotech Results
August 19, 2025 02:14 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) reports mixed fiscal year results impacting share performance.,Restructuring plans include staffing reductions and a share buy-back program.,Revenue and underlying EBIT fall short of consensus, while NPATA remains aligned wit...
Lumos Diagnostics Advances FebriDx with FDA Waiver Application Amid ASX 200 Stocks Momentum
August 18, 2025 11:05 AM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics submits CLIA waiver application for FebriDx,Clinical study supports ease of use for broader access,Partnership set to strengthen US market adoption,Lumos Diagnostics (ASX:LDX) has taken a major step forward by submitting...
Strategic Alliance Brings FebriDx® to the Forefront of U.S. Healthcare
August 14, 2025 07:52 PM AEST| By Team Kalkine MediaHighlights,Strategic alliance accelerates FebriDx® adoption across U.S. healthcare.,PRO-spectus provides comprehensive support for reimbursement and market access.,Effort aims to improve diagnosis and curb unnecessary antibiotic use.,Lumos Diagnostic...
ASX200 Pro Medicus (ASX:PME) Records Strong FY2025 Growth and Expands Global Reach
August 14, 2025 05:56 PM AEST| By Team Kalkine MediaHighlights,Achieved record revenue in FY2025,Strong US market contracts drive performance,Margins reached highest level to date,Pro Medicus posted record-breaking results for FY2025, reinforcing its position as one of the notable performers within th...
ASX 200 Healthcare Stock Gains Attention in S&P/ASX Indices
August 14, 2025 05:04 PM AEST| By Team Kalkine MediaHighlights,Neuren Pharmaceuticals (ASX:NEU) operates in the biotechnology sector with a focus on central nervous system conditions,Lead therapy Daybue, licensed to Acadia (NASDAQ:ACAD), records continued growth in the US market,Preparations underway...
A Closer Look at Cochlear Ltd (ASX:COH): Key Metrics That Shape Its Valuation
August 14, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,Key metrics offer insight into valuation and performance.,Cochlear Ltd (COH) operates from a strong financial foundation.,Innovation and global demand underpin long-term outlook.,Cochlear Ltd (ASX:COH) is part of the,ASX 200,stocks, reflec...
ASX 200 Futures Pro Medicus Records Strong Year with Major Global Contracts
August 14, 2025 03:04 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus secures multiple long-term healthcare contracts.,Cloud-native imaging solutions see increased adoption.,Pipeline expands into new medical specialties and AI.,The,ASX 200 Futures,segment has seen notable activity, with Pro Medic...
Exploring Pro Medicus Ltd (ASX:PME) in the ASX 100 Healthcare Space
August 13, 2025 05:38 PM AEST| By Team Kalkine MediaHighlights,Radiology software solutions supporting global healthcare providers,Consistent revenue streams driven by essential medical services,Expanding role of healthcare technology in diagnostic efficiency,Understanding the PME Landscape,Pro Medicu...
ASX 200 Orthocell expands Remplir rollout in United States nerve repair sector
August 13, 2025 04:43 PM AEST| By Team Kalkine MediaHighlights,Orthocell (ASX:OCC) advances Remplir adoption across multiple US hospitals,Value Assessment Committee approvals continue to progress in the US market,Distribution and logistics network strengthened to support expanding demand,ASX 200,liste...
ASX 200 small caps update: Orthocell expands US presence, Antipa adds expertise, European Lithium advances project
August 13, 2025 04:37 PM AEST| By Team Kalkine MediaHighlights,Orthocell (ASX:OCC) strengthens commercial rollout of Remplir in the United States,Antipa Minerals (ASX:AZY) appoints experienced industry professional to its board,European Lithium (ASX:EUR) engages NIRAS for Tanbreez Rare Earth Project D...
ASX 200 biotechnology company Clarity Pharmaceuticals updates clinical progress
August 13, 2025 04:24 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) secures funding to progress full clinical program,Upcoming therapeutic trial to proceed without external partnership,Upcoming data release expected to differentiate its PSMA imaging agent,ASX 200,listed Cl...
Orthocell Moves Ahead with Remplir™ Rollout in US Nerve Repair Market
August 13, 2025 10:52 AM AEST| By Team Kalkine MediaHighlights,Expansion of Remplir™ adoption in the US market,Strategic VAC approvals progressing across key hospitals,Strengthened logistics and specialist team support in place,Orthocell Ltd (ASX:OCC) is advancing its presence in the US nerve repair m...
Opyl’s AI Platform Secures Exclusive Role in Clinical Trial Risk Solutions
August 12, 2025 06:49 PM AEST| By Team Kalkine MediaHighlights,Opyl’s (OPL) TrialKey platform to act as exclusive calculation agent in global biotech insurance products,Partnership provides continuous access to diverse clinical trial data for AI model enhancement,Collaboration targets reducing trial f...
Recce Pharmaceuticals’ Innovative Topical Gel Shows Strong Burn Wound Recovery Results
August 12, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,New topical gel demonstrates strong results in infection control,Study shows improved healing rates in burn wound models,Backed by a US Department of Defense research program,Recce Pharmaceuticals Ltd (ASX:RCE) has shared new pre-clinical...
Tryptamine Strengthens Clinical Pathway with New R&D Facility Funding
August 12, 2025 04:08 PM AEST| By Team Kalkine MediaHighlights,Secures multi-million-dollar R&D loan facility,Advancing world-first Binge Eating Disorder trial,Exploring wider clinical applications for psilocin therapy,Tryptamine Therapeutics Ltd (ASX:TYP) has expanded its financial capacity through a...
Prescient Therapeutics Moves Ahead with Funding to Boost Cancer Therapy Development
August 12, 2025 11:28 AM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics progresses with latest funding round,Funds directed toward PTX-100 clinical advancements,Global trial participation continues for CTCL treatment,Prescient Therapeutics Ltd (ASX:PTX), a clinical-stage oncology company...
Anteris Technologies Advances Global Clinical Program for DurAVR® THV
August 12, 2025 11:24 AM AEST| By Team Kalkine MediaHighlights,Clinical adoption expands for DurAVR® THV,Milestone achievement with world-first dual valve procedure,Preparations progress for pivotal PARADIGM Trial,Anteris Technologies Ltd (ASX:AVR) reported steady progress in the second quarter of 202...
Imugene Extends SPP Deadline Amid Clinical Trial Progress
August 12, 2025 11:13 AM AEST| By Team Kalkine MediaHighlights,Extended SPP closing date to provide more participation time,Strong trial results for lead CAR T-cell therapy program,Expanded trial to cover new lymphoma subtypes,Imugene Ltd (ASX:IMU) has announced an extension to its Share Purchase Plan...
ASX 200 Ansell (ASX:ANN) momentum within materials and healthcare
August 11, 2025 05:43 PM AEST| By Team Kalkine MediaHighlights,Share price resilience aligns with broader sentiment despite earnings softness for (ASX:ANN),Total return benefits from distributions add to long horizon outcomes,Insider on-market activity and revenue shifts shape the narrative without al...
Advertise your brand on Kalkine Media